PPARGC1A and Huntington disease: In this context, researchers described the modulation of the pro-oxidant and pro-inflammatory environment by anti-inflammatory microglia via the PGC-1α pathway, suggesting its therapeutic potential in HD-driven neuroinflammation [35].